Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.39 USD | +1.70% | +10.98% | +29.08% |
04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.08% | 524M | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-14.16% | 31.67B | |
+51.20% | 24.62B | |
-14.47% | 15.65B | |
-13.89% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- KeyBanc Downgrades Avid Bioservices to Sector Weight From Overweight